IMMUNITYBIO INC (IBRX) Stock Analyst Ratings
NASDAQ:IBRX • US45256X1037
10.365 USD
-1.19 (-10.26%)
Last: Feb 25, 2026, 11:43 AM
ChartMill assigns a Buy % Consensus number of 85% to IBRX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 12.04. This target is 16.12% above the current price.
- IBRX was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about IBRX.
- In the previous month the buy percentage consensus was at a similar level.
- IBRX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-23 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-02-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-02-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-02-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-23 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-23 | BTIG | Maintains | Buy -> Buy |
| 2026-01-20 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-20 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-12 | Jefferies | Maintains | Buy -> Buy |
| 2025-12-11 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-20 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-05-12 | D. Boral Capital | Maintains | Buy -> Buy |
IMMUNITYBIO INC / IBRX FAQ
Can you provide the average price target for IMMUNITYBIO INC stock?
11 analysts have analysed IBRX and the average price target is 12.04 USD. This implies a price increase of 16.12% is expected in the next year compared to the current price of 10.365.
What is the consensus rating for IMMUNITYBIO INC (IBRX) stock?
The consensus rating for IMMUNITYBIO INC (IBRX) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.